|
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate – whether as a standalone cloud application or as an integrated extension of ZEISS FORUM – enabling secure data sharing, structured referrals, and real-time clinical coordination to strengthen continuity of care across the ophthalmic workflow.
JENA, Germany, Feb. 23, 2026 /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today launched its ZEISS Collaborative Care browser-based software application enabling eye care professionals to seamlessly work together securely sharing data, referring patients, and strengthening their professional networks. The new solution addresses longstanding challenges in ophthalmic care, particularly fragmented data sharing, and inefficient referral processes. By enabling real-time communication, structured referrals, and shared clinical insights, ZEISS Collaborative Care empowers providers to make fast and confident clinical decisions.
ZEISS Collaborative Care will be demonstrated for the first time at the 100% Optical 2026 congress in London from Feb. 28 to March 2, and then again at the Vision Expo event in Orlando, FL, from March 11 to 14.
"At ZEISS, we've focused the strengths of our digital expertise to address some of the persistent challenges in a patient's healthcare journey. Working closely with our customers, we've laid the foundation to transform continuity of care today, supported by data-driven, digital care models that can follow patients throughout their ophthalmic care pathway. ZEISS Collaborative Care is an important step forward in our vision, bringing care teams closer together for more efficient patient care," says Magnus Reibenspiess, Chief Commercial Officer and Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology.
A new standard for connected care
ZEISS Collaborative Care is delivered as an application of the ZEISS Healthcare Data Platform (HDP), which provides the secure cloud foundation behind our digital solutions. As an HDP-powered application, it offers flexible deployment for practitioners to support a wide range of clinical environments. Practices may use it as a standalone cloud solution or as a connected extension of ZEISS FORUM allowing diagnostic data, images, and insights to flow seamlessly from on-premises systems into secure, browser-based collaboration spaces. This flexibility ensures providers – regardless of their current digital infrastructure – can participate in efficient, data-driven care pathways.
ZEISS Collaborative Care offers an intuitive set of real-time collaboration tools, ensuring clinical data moves with the patient, supporting better decisions and more coordinated care. It integrates smoothly into existing ZEISS solutions and adheres to industry standard security requirements, enabling eye care professionals to collaborate with confidence.
SHARE – exchange insights and data to enhance decision-making
- Securely exchanging images, reports and patient data to obtain second opinions and foster more confident clinical decision-making.
- Consult with peers on challenging cases to validate assessments and determine the best care pathway for patients.
- Communicate in real-time via chat and stay updated with email notifications.
REFER – streamline referral workflows
- Send, track and prioritize referrals through a user-friendly, secure browser-based application, ensuring the right data gets to the right provider at the right time.
- Facilitate seamless patient care updates between referring and receiving practitioners, optimizing the patient journey from consultation to specialist care.
- Easily receive and download patient data into the eye care professional's system for comprehensive analysis and documentation.
NETWORK – strengthen professional networks to improve continuity of care
- Build stronger professional connections and trust between optometrists and ophthalmologists, and foster an open network dedicated to better patient care.
- Exchange clinical knowledge and access peer support anytime, anywhere to enhance the eye care professional's practice.
- Collaborate within a professional network via a browser, independent of any one data management system.
For more information about ZEISS Collaborative Care visit here.
Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.
Contact for investors:
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.med@zeiss.com
Contact for the press:
Frank Smith
Head of Global Communications
Ophthalmology, Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: press.med@zeiss.com
Company Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).
The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate – whether as a standalone cloud application or as an integrated extension of ZEISS FORUM – enabling secure data sharing, structured referrals, and real-time clinical coordination to strengthen continuity of care across the ophthalmic workflow.
JENA, Germany, Feb. 23, 2026 /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today launched its ZEISS Collaborative Care browser-based software application enabling eye care professionals to seamlessly work together securely sharing data, referring patients, and strengthening their professional networks. The new solution addresses longstanding challenges in ophthalmic care, particularly fragmented data sharing, and inefficient referral processes. By enabling real-time communication, structured referrals, and shared clinical insights, ZEISS Collaborative Care empowers providers to make fast and confident clinical decisions.
ZEISS Collaborative Care will be demonstrated for the first time at the 100% Optical 2026 congress in London from Feb. 28 to March 2, and then again at the Vision Expo event in Orlando, FL, from March 11 to 14.
"At ZEISS, we've focused the strengths of our digital expertise to address some of the persistent challenges in a patient's healthcare journey. Working closely with our customers, we've laid the foundation to transform continuity of care today, supported by data-driven, digital care models that can follow patients throughout their ophthalmic care pathway. ZEISS Collaborative Care is an important step forward in our vision, bringing care teams closer together for more efficient patient care," says Magnus Reibenspiess, Chief Commercial Officer and Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology.
A new standard for connected care
ZEISS Collaborative Care is delivered as an application of the ZEISS Healthcare Data Platform (HDP), which provides the secure cloud foundation behind our digital solutions. As an HDP-powered application, it offers flexible deployment for practitioners to support a wide range of clinical environments. Practices may use it as a standalone cloud solution or as a connected extension of ZEISS FORUM allowing diagnostic data, images, and insights to flow seamlessly from on-premises systems into secure, browser-based collaboration spaces. This flexibility ensures providers – regardless of their current digital infrastructure – can participate in efficient, data-driven care pathways.
ZEISS Collaborative Care offers an intuitive set of real-time collaboration tools, ensuring clinical data moves with the patient, supporting better decisions and more coordinated care. It integrates smoothly into existing ZEISS solutions and adheres to industry standard security requirements, enabling eye care professionals to collaborate with confidence.
SHARE – exchange insights and data to enhance decision-making
- Securely exchanging images, reports and patient data to obtain second opinions and foster more confident clinical decision-making.
- Consult with peers on challenging cases to validate assessments and determine the best care pathway for patients.
- Communicate in real-time via chat and stay updated with email notifications.
REFER – streamline referral workflows
- Send, track and prioritize referrals through a user-friendly, secure browser-based application, ensuring the right data gets to the right provider at the right time.
- Facilitate seamless patient care updates between referring and receiving practitioners, optimizing the patient journey from consultation to specialist care.
- Easily receive and download patient data into the eye care professional's system for comprehensive analysis and documentation.
NETWORK – strengthen professional networks to improve continuity of care
- Build stronger professional connections and trust between optometrists and ophthalmologists, and foster an open network dedicated to better patient care.
- Exchange clinical knowledge and access peer support anytime, anywhere to enhance the eye care professional's practice.
- Collaborate within a professional network via a browser, independent of any one data management system.
For more information about ZEISS Collaborative Care visit here.
Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.
Contact for investors:
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.med@zeiss.com
Contact for the press:
Frank Smith
Head of Global Communications
Ophthalmology, Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: press.med@zeiss.com
Company Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).
The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
|
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Feb. 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE="
John Deere will preview CONEXPO on NYSE Live jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4', image: 'https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4?p=thumbnail', autostart:'false', stretching : 'uniform', width: '512', height: '288'});
Ashley Mastronardi delivers the pre-market update on February 23rd
- The New York Stock Exchange and equities markets will open today, as normal, despite the Northeast being hit by a historic winter blizzard.
- Leaders from CONEXPO-CON/AGG, billed as North America's largest construction trade show, will join NYSE Live ahead of its next convention in Las Vegas in early March.
- The space industry is lifting off with fresh rounds of funding, with leaders from Gilmour Space and Aalyria joining NYSE Live to discuss how it will accelerate their growth.
- The ViVE 2026 digital health conference kicked off in Los Angeles on Sunday and NYSE is on the ground with content set to roll out across out platforms in the coming weeks.
Opening Bell
CONEXPO-CON/AGG celebrate the kickoff of North America's largest construction trade show
Closing Bell
NYSE Floor Brokers ring the Closing Bell
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com
Video - https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Feb. 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
John Deere will preview CONEXPO on NYSE Live jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4', image: 'https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4?p=thumbnail', autostart:'false', stretching : 'uniform', width: '512', height: '288'});
Ashley Mastronardi delivers the pre-market update on February 23rd
- The New York Stock Exchange and equities markets will open today, as normal, despite the Northeast being hit by a historic winter blizzard.
- Leaders from CONEXPO-CON/AGG, billed as North America's largest construction trade show, will join NYSE Live ahead of its next convention in Las Vegas in early March.
- The space industry is lifting off with fresh rounds of funding, with leaders from Gilmour Space and Aalyria joining NYSE Live to discuss how it will accelerate their growth.
- The ViVE 2026 digital health conference kicked off in Los Angeles on Sunday and NYSE is on the ground with content set to roll out across out platforms in the coming weeks.
Opening Bell
CONEXPO-CON/AGG celebrate the kickoff of North America's largest construction trade show
Closing Bell
NYSE Floor Brokers ring the Closing Bell
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com
Video - https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard
